(Press-News.org) Gene therapy has emerged as a revolutionary approach to treating genetic disorders by directly addressing underlying genetic abnormalities. However, the success of gene therapy hinges on the efficient and safe delivery of therapeutic genes to target cells. Traditional viral vectors, despite their high transfection efficiency, face limitations such as immunogenicity, limited cargo capacity, and risks of insertional mutagenesis. Non-viral gene delivery systems, particularly those based on macromolecular carriers, have gained prominence as safer and more versatile alternatives. This review explores the advancements in synthetic and natural polymer-based gene delivery systems, highlighting their design, mechanisms, and therapeutic potential.
Role of Macromolecules in Gene Delivery Systems
Macromolecular carriers, including synthetic and natural polymers, offer significant advantages such as biocompatibility, controlled gene release, and targeted delivery. These systems are categorized into various types, such as cationic polymers, dendrimers, and hybrid nanomaterials, each with unique physicochemical properties that influence their gene delivery efficiency. Compared to viral vectors, non-viral systems exhibit lower immunogenicity and greater design flexibility, making them suitable for diverse therapeutic applications.
Targeting Strategies of Macromolecules for Non-viral Gene Therapy
Functional polymers can be engineered with targeting ligands or stimuli-responsive elements to enhance specificity and efficiency. Natural polymers like chitosan, hyaluronic acid (HA), and dextran are particularly notable for their biodegradability and low toxicity. For example, chitosan's pH-sensitive behavior and mucoadhesive properties make it ideal for oral and nasal delivery, while HA's affinity for CD44 receptors enables tumor-specific targeting. Synthetic polymers, such as polyethyleneimine (PEI) and poly(L-lysine) (PLL), are widely used for their strong nucleic acid binding and endosomal escape capabilities but often require modifications to reduce cytotoxicity.
Cationic Polymers
Cationic polymers, including PEI, PLL, and poly(β-amino ester)s (PBAEs), play a crucial role in gene delivery by forming stable polyplexes with nucleic acids. PEI's high charge density facilitates efficient transfection, but its cytotoxicity necessitates modifications like PEGylation. PBAEs, known for their biodegradability and pH-responsive properties, have shown promise in delivering plasmid DNA and RNA molecules with minimal toxicity. Dendritic polymers, such as poly(amidoamine) (PAMAM) dendrimers, offer precise structures and high transfection efficiency but require optimization to balance efficacy and safety.
Conjugation-Based and Star Polymers
Conjugation-based systems, like polyplex micelles, integrate hydrophobic cores and PEG shells to improve circulation time and targeting. Star polymers, with their branched architectures, exhibit high gene-loading capacity and enhanced cellular uptake. For instance, star-shaped PEI-g-PEG polymers have demonstrated reduced toxicity and improved transfection efficiency in retinoblastoma therapy.
Comb and Brush Polymers
Comb polymers, with their hydrophobic backbones and oligolysine side chains, provide efficient gene transport and protection. Brush polymers, particularly those with PEG-based structures, enhance nuclease stability and cellular uptake, making them suitable for siRNA delivery. These architectures highlight the importance of polymer design in achieving optimal gene delivery outcomes.
Limitations and Future Perspectives
Despite their potential, polymer-based gene delivery systems face challenges such as lower transfection efficiency compared to viral vectors, cytotoxicity, and batch-to-batch variability. Future research aims to develop "smart" polymers that respond to cellular stimuli, integrate multifunctional components for targeted delivery, and leverage natural polymers for improved biocompatibility. Advances in nanotechnology and hybrid systems are expected to overcome physiological barriers, such as the blood-brain barrier, further expanding therapeutic applications.
Conclusions
Macromolecular gene delivery systems represent a promising frontier in non-viral gene therapy, offering a balance of safety, versatility, and efficacy. By addressing current limitations through innovative polymer design and targeted strategies, these systems hold the potential to revolutionize the treatment of genetic disorders and complex diseases like cancer. Continued research and preclinical studies will be essential to translate these advancements into clinical practice.
Full text
https://www.xiahepublishing.com/2572-5505/JERP-2025-00009
The study was recently published in the Journal of Exploratory Research in Pharmacology.
Journal of Exploratory Research in Pharmacology (JERP) publishes original innovative exploratory research articles, state-of-the-art reviews, editorials, short communications that focus on novel findings and the most recent advances in basic and clinical pharmacology, covering topics from drug research, drug development, clinical trials and application.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
New study redefines healthy aging as an environmental, social, and political phenomenon, and calls on public health strategies to expand beyond lifestyle prescriptions to address structural inequalities and governance deficits
A groundbreaking international study of 161,981 participants across 40 countries published in Nature Medicine today, [Monday , 14th July 2025] reveals that air pollution, social inequality, and weak democratic institutions substantially accelerate aging. The collaborative study involves leading researchers from the Global Brain Health Institute in Trinity ...
Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for the most critical patients.
The study, published in the journal Immunity, was conducted on 72 adult travellers diagnosed with malaria at Karolinska University Hospital after returning from tropical regions.
By analysing blood samples from these individuals, who were followed for a year, the researchers were able to identify around ...
About The Study: The findings of this study suggest that delays in hypertension diagnosis were common and significantly associated with delays in treatment initiation and adverse cardiovascular outcomes, underscoring the need for earlier identification and intervention.
Corresponding Author: To contact the corresponding author, John E. Brush Jr, MD, email jebrush@sentara.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.20498)
Editor’s Note: Please see the article for additional ...
About The Study: Glucagon-like peptide 1 receptor agonist (GLP-1 RA) therapy in idiopathic intracranial hypertension is associated with significant reductions in medication use, symptoms/signs, and procedural interventions, suggesting its potential as a management strategy. Further prospective studies are warranted to confirm these findings.
Corresponding Author: To contact the corresponding author, Dennis J. Rivet II, MD, email dennis.rivet@vcuhealth.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2025.2020)
Editor’s Note: Please ...
About The Article: This article provides practical strategies for symptom management for patients receiving glucagon-like peptide-1 and dual receptor agonists (GLP-1 RAs) to manage weight and suggests interventions supporting muscle and nutrient preservation during GLP-1 RA treatment.
Corresponding Author: To contact the corresponding author, JoAnn E. Manson, MD, DrPH, email jmanson@bwh.harvard.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2025.1794)
Editor’s ...
FOR IMMEDIATE RELEASE: July 14, 2025
CONTACT: Camille Jewell
cjewell@vancomm.com or 202-248-5460
NASHVILLE — Research presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting included three studies that explored the differences in treatment and recovery options for patients across racial, gender and socioeconomic lines in a large telestroke network in Pennsylvania and a university medical center in Rhode Island.
Telestroke treatment aims to improve care for people with stroke symptoms who live far from comprehensive stroke centers — hospitals that offer a full ...
“[…] manipulating LD dynamics represents a promising strategy to overcome hypoxia-induced resistance to ferroptosis and improve the success of PCa treatment.”
BUFFALO, NY – July 14, 2025 – A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled “Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer.”
In this study, researchers led by Shailender S. Chauhan and Noel A. Warfel from the University of Arizona discovered that prostate cancer cells survive treatment ...
A bottleneck in ensuring access to widespread molecular diagnostics, especially in low- and middle-income countries, has been the high cost and logistical complexities associated with rapid, point-of-care tests. Now, a collaborative research effort outlined in a Life Science Alliance (LSA) study to be published July 14, 2025 has addressed these challenges by developing a lyophilized (freeze-dried) open-source reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for pathogen detection. This method, successfully applied to COVID-19, aims to make the diagnostics more accessible and affordable globally.
In ...
AMHERST, Mass. — While popular culture commonly depicts extraterrestrial life as little green men with large, oval-shaped heads, it’s most likely that if there is life beyond our planet and within our solar system, it is microbial. Recently, NASA awarded University of Massachusetts Amherst microbiologist James Holden $621,000 to spend the next three years using his expertise to help predict what life on Jupiter’s moon Europa might look like. For that, Holden turned to an unexpected place: the volcanoes a mile beneath our own oceans.
Jupiter’s moon, Europa, has a frozen surface, but astronomers believe that beneath all that ice lies a salty, liquid ocean ...
SAN ANTONIO — July 14, 2025 — Southwest Research Institute (SwRI) is taking on the challenges of a hydrogen-powered future. In collaboration with NYSEARCH, a nonprofit research and development organization for the gas industry serving utility members across North America, SwRI is investigating how blending hydrogen into liquid natural gas (LNG) could affect the integrity of the LNG storage tanks.
Natural gas is widely used to power appliances and heat homes. By blending hydrogen into ...
